Who is the CEO of Moogene Medi?

According to the DART company overview, Moogene Medi's representative director is 윤태종 (name as registered in Korean). The company was founded on 2016-06-22.

Where is Moogene Medi listed?

Moogene Medi trades on the Korea Exchange KONEX market under the ticker 322970. Its fiscal year ends in December.

Does Moogene Medi pay a dividend?

Moogene Medi did not pay a cash dividend for fiscal 2025, according to its annual report.

Which companies are in the same industry as Moogene Medi?

Under the Korean Standard Industrial Classification recorded on DART, Moogene Medi is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.

Moogene Medi KRX:322970KONEX

무진메디 · Korean news coverage and regulatory filings, organized.

한국어

Articles, 24h0

Articles, 7 days0

DART filings, 7 days1

Articles tracked0since Sep 11

Moogene Medi (무진메디) appeared in 0 Korean news articles and 1 DART filing over the past seven days.

Moogene Medi top stories 2 weeks, by number of outlets

No story covered by multiple outlets in the past two weeks.

Latest Moogene Medi news Korean headlines

No articles yet.

Articles per day 2 weeks

Company profile

CEO: 윤태종
Industry: Medical & pharmaceutical R&D
Founded: 2016-06-22
Fiscal year-end: December
Head office: 경기도 하남시
Website: moogene.com
Quotes & chart: Naver Securities (Korean)

From the DART company overview.

Same industry Medical & pharmaceutical R&D

All in industry

Company	Latest quarter op. profit	Articles 30d
Alteogen	₩34.2bn	55
Qurient	−₩12.8bn	26
Vaxcell-Bio Therapeutics	−₩5.0bn	22
OliX Pharmaceuticals	−₩14.0bn	20
Penetrium Bioscience	−₩1.9bn	19
Aribiolab	−₩2.5bn	15
LigaChem Biosciences	−₩72.0bn	14
ImmuneOncia Therapeutics	−₩4.3bn	14

Compare Moogene Medi side by side with these companies

Moogene Medi DART filings

Sep 2816:31

Other 전환가액의조정 (제2회차)
Other
Sep 1810:44

Investor relations event 기업설명회(IR)개최
Other

Mentioned alongside 2 weeks

No co-mentioned companies yet.

Moogene Medi FAQ

Who is the CEO of Moogene Medi?: According to the DART company overview, Moogene Medi's representative director is 윤태종 (name as registered in Korean). The company was founded on 2016-06-22.
Where is Moogene Medi listed?: Moogene Medi trades on the Korea Exchange KONEX market under the ticker 322970. Its fiscal year ends in December.
Does Moogene Medi pay a dividend?: Moogene Medi did not pay a cash dividend for fiscal 2025, according to its annual report.
Which companies are in the same industry as Moogene Medi?: Under the Korean Standard Industrial Classification recorded on DART, Moogene Medi is grouped with 52 other listed companies in medical & pharmaceutical r&d. The most covered in Korean news over the past 30 days are Alteogen, Qurient and Vaxcell-Bio Therapeutics.